CVE-2025-48981

CVE-2025-48981 is a high-severity vulnerability with a CVSS 3.x base score of 8.6. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-311.

Key facts

Description

An insecure implementation of the proprietary protocol DNET in Product CGM MEDICO allows attackers within the intranet to eavesdrop and manipulate data on the protocol because encryption is optional for this connection.

Frequently asked questions

What is CVE-2025-48981?
An insecure implementation of the proprietary protocol DNET in Product CGM MEDICO allows attackers within the intranet to eavesdrop and manipulate data on the protocol because encryption is optional for this connection.
How severe is CVE-2025-48981?
CVE-2025-48981 has a CVSS 3.x base score of 8.6, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity low, and availability low.
Is CVE-2025-48981 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (2nd percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2025-48981?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2025-48981 have an EU (EUVD) identifier?
Yes. CVE-2025-48981 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-31860.
When was CVE-2025-48981 published?
CVE-2025-48981 was published on 2025-10-08 and last updated on 2026-06-17.

References

Other CWE-311 (Missing Encryption of Sensitive Data) vulnerabilities

Browse all CWE-311 (Missing Encryption of Sensitive Data) vulnerabilities →